跳至主要内容
临床试验/NCT02593864
NCT02593864已完成不适用

A Novel Serum Biomarker Stress Test for Detection of Early Osteoarthritis

VA Palo Alto Health Care System2 个研究点 分布在 1 个国家目标入组 25 人开始时间: 2016年2月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
25
试验地点
2
主要终点
Change at 6 Months From Baseline in First Peak Knee Adduction Moment (KAM): (6 Month Value - Baseline)

研究概览

简要总结

Veterans have much higher risk of osteoarthritis (OA) then the general population. Knee OA is common among Veterans and is a leading cause of disability. The earliest stages of OA development, where the joint cartilage wears away, is usually painless. By the time Veterans experience symptoms, the OA is typically advanced and there is nothing that can be done except palliation until the joint is replaced with metal and plastic. If there was a blood test to provide early warning of cartilage wear and joint deterioration, Veterans could potentially be treated early enough to slow down or even prevent OA. So far, development of such a blood test has proved elusive. The investigators propose a new method to amplify the signs of cartilage wear in the blood by challenging the affected joint with a walking task. Similar to a cardiac stress test, this walking challenge may help to separate joints at risk from healthy joints. The investigators will also see if this 'OA stress test' can show if a simple and inexpensive load-modifying shoe can improve joint health in Veterans with early knee OA.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Basic Science
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • age 18-80 years
  • symptomatic medial compartment knee OA (KL grades 0-2)
  • full weight-bearing status
  • able to walk for 30 minutes or longer
  • able to undergo MRI scan
  • agreement and ability to use provided shoe as primary walking shoe (4 or more hours a day) during the 6 month study period

排除标准

  • inflammatory arthritis, gout or recurrent pseudogout
  • patellofemoral or lateral compartment disease that is equal to or more extensive than medial disease
  • symptomatic OA of other lower extremity joints
  • BMI >35 kg/m2
  • prior structural surgery of the knee except for medial meniscectomy performed > 6 months prior
  • use of shoe insert or hinged knee brace
  • pes planus, and/or unusual foot size or shape

结局指标

主要结局

Change at 6 Months From Baseline in First Peak Knee Adduction Moment (KAM): (6 Month Value - Baseline)

时间窗: Baseline to 6 months

Knee adduction moment describes the medial/lateral load distribution of the knee measured while walking in a gait laboratory. Before normalization to account for size, the knee adduction moment is expressed in Nm. However, to account for different sized people, the knee adduction moment is transformed and expressed in percentage of body weight times height (%BW\*ht). Higher knee adduction moments have been linked to more severe osteoarthritis (OA). Knee adduction moment will be analyzed at baseline and after 6 months of variable-stiffness shoe wear. Values at 6 months (in variable-stiffness shoe) will be compared to baseline (in control shoe).

Change at 6 Months From Baseline in Serum COMP Biomarker Levels in Response to a Mechanical Stimulus (6 Month - Baseline)

时间窗: Baseline to 6 months

Serum samples were collected before and after a 30 minute walking activity. Levels of serum cartilage oligomeric matrix protein (COMP) 3.5 hours following the 30-minute walk, expressed as a percentage of pre-activity resting values, were assessed, and values at 6 months were compared to baseline.

次要结局

未报告次要终点

研究者

发起方
VA Palo Alto Health Care System
申办方类型
Fed
责任方
Principal Investigator
主要研究者

Constance Chu, MD

Director, Joint Preservation Center

VA Palo Alto Health Care System

研究点 (2)

Loading locations...

相似试验